The Changing Landscape and Advances in the Treatment of Multiple Myeloma
Speakers
Sam Fazeli
Head of EMEA Research
Bloomberg
Sam Fazeli is a senior analyst and the EMEA head of Bloomberg Intelligence, a dynamic platform for in-depth research available on the Bloomberg Professional service at BI . Dr. Fazeli specializes in global pharmaceuticals, bringing over 20 years of experience conducting equity research as a pharmaceutical analyst, working at firms such as Nomura International and HSBC. Prior to joining Bloomberg in 2010, Dr. Fazeli worked at Piper Jaffray, Ltd. as a pharmaceutical analyst and head of European research. Before transitioning to investment banking, he was a research scientist for seven years. Dr. Fazeli has been ranked a top analyst by both the U.K. and Pan-European Extel surveys. He received a bachelor’s of science from Cardiff University, and a Ph.D. in pharmacology from the University of London.
Dr. Andrew Yee
Clinical Director, Center for Multiple Myeloma
Massachusetts General Hospital, Education Center
Andrew Yee, MD, is an Assistant Professor of Medicine at Harvard Medical School (07/2007 - Present) and is Clinical Director at the Center for Multiple Myeloma at Massachusetts General Hospital Cancer Center (07/2007 - Present) His clinical and research focus is multiple myeloma and related conditions; he actively sees patients as their primary oncologist or consultant. He is the principal investigator of several trials for patients with relapsed multiple myeloma.